Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pang Yong Kek
Impact of Second-Line Treatment on Overall Survival of Advanced Lung Adenocarcinoma Patients
Related publications
Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients
Korean Journal of Internal Medicine
Internal Medicine
P026 Impact of Prior Cancer History on the Overall Survival of Younger Patients With Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Iron Accumulation in Tumor-Associated Macrophages Marks an Improved Overall Survival in Patients With Lung Adenocarcinoma
Scientific Reports
Multidisciplinary
Establishment of a First‑line Second‑line Treatment Model for Human Pulmonary Adenocarcinoma
Oncology Letters
Cancer Research
Oncology
Prolonged Response to First-Line Erlotinib for Advanced Lung Adenocarcinoma
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
P068 the Geriatric Nutritional Risk Index Predicts the Overall Survival in Geriatric Patients With Metastatic Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
An Evaluation of the Impact of Missing Deaths on Overall Survival Analyses of Advanced Non–small Cell Lung Cancer Patients Conducted in an Electronic Health Records Database
Pharmacoepidemiology and Drug Safety
Epidemiology
Pharmacology
A Five‑long Non‑coding RNA Signature With the Ability to Predict Overall Survival of Patients With Lung Adenocarcinoma
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Prm256 - Adjustment for the Impact of Subsequent Therapies Not Available in Uk on Overall Survival (Os) in Castor Trial: A Subgroup Analysis in Second-Line (2l) Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
